Fate Therapeutics (FATE) Other Gross PP&E Adjustments (2016 - 2025)
Fate Therapeutics (FATE) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with $44.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 0.81% year-over-year to $44.8 million, compared with a TTM value of $44.8 million through Dec 2025, down 0.81%, and an annual FY2025 reading of $44.8 million, down 0.81% over the prior year.
- Other Gross PP&E Adjustments was $44.8 million for Q4 2025 at Fate Therapeutics, up from -$42.4 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $82.8 million in Q4 2023 and bottomed at -$69.5 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$31.0 million, with a median of -$60.1 million recorded in 2024.
- The sharpest move saw Other Gross PP&E Adjustments surged 259.43% in 2021, then tumbled 45.43% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $37.8 million in 2021, then surged by 96.89% to $74.3 million in 2022, then increased by 11.37% to $82.8 million in 2023, then crashed by 45.43% to $45.2 million in 2024, then fell by 0.81% to $44.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for FATE at $44.8 million in Q4 2025, -$42.4 million in Q3 2025, and -$43.8 million in Q2 2025.